(A) Flow cytometry against Fzd7+myc+, myc+, and WT CHO cells. minimal rounds of selection. == Introduction == Phage display is an antibody discovery tool that screens AZD4547 bacteriophage presenting a library of variable antibody domains against a AZD4547 target antigen. Through multiple rounds of incubation with the target, washing away unbound phage, and amplifying AZD4547 bound phage, the library is usually reduced to those clones with affinity and specificity to the antigen.1,2Individual clones can be selected or screened from this sublibrary and converted into an IgG format for use as diagnostic or therapeutic reagents. Though effective, traditional phage display suffers from key limitations. Conventionally, >5 rounds of selection are required to generate clones with high affinity to the target. The cost and time requirements of repeat rounds (approximately 68 weeks and $8,00010,000 USD in total) are a bottleneck in the discovery of new therapeutics.3,4The difficulty in controlling stringency during binding causes many candidates from the enriched phage pools to represent false positives that failin vitrovalidation.5,6An inability to recapitulate the low relative concentration and morphology of targetsin vitromay also lead to candidates failing later duringin vivotesting.7The stochastic nature of selection results in thousands of nonspecific clones, requiring further screening for elimination. Further, variations in the efficiency of bacterial amplification result in candidates being missed due to low representation.8,9 To address these issues, variations of the phage display approach have been developed. These include performing selection with antigens presented on a cell surface10and with mixed cell types,11incorporating microfluidics to control the binding dynamics,12,13and using next-generation sequencing (NGS) and bioinformatics analysis to choose clones for validation, to further library design,14or to eliminate nonspecific clones.15 Although the feasibility of these approaches has been explored, a comprehensive platform combining these novel features to produce high-performing antibodies in a reduced number of rounds against a challenging therapeutic target has yet to be demonstrated. In this paper, we present such a platform: Cellect. To recapitulate thein vivobinding environment, antigens are presented on the surface of a cell with a large background of nonspecific cell types. By modifying the ratio of cell types, different levels of stringency can be applied to the selection. To eliminate amplification bias, a very high sampling rate is achieved by using a large number of cells (>107). To choose clones, all phage pools are sequenced and an unsupervised machine learning algorithm selects top clones based on structural trends in the entire data set and enrichment scores. With this workflow, the number of rounds required to discover quality candidates is usually reduced. By using low-cost microfluidic devices and open-source software, the cost per round of selection is also AZD4547 kept low, making it appealing Rabbit Polyclonal to Glucokinase Regulator for widespread deployment. == Design Overview == Cellect (Physique1A) begins with the incubation of a nave phage library with a heterogeneous mixture consisting of a minority of cells expressing the target antigen and a large background of a cell type lacking the target. Target cells are then labeled with magnetic nanoparticles (MNPs) specific to a capture probe and sorted using a microfluidic cell sorter (MICS).16 == Determine 1. == Overview of Cellect. (A) Schematic overview of the Cellect methodology. HTS: high-throughput sequencing. (B) The microfluidic cell sorter (MICS) chip uses patterned guides to separate cells based on protein expression. Deflection caused by combined Stokes drag force (from fluid flow, toward stores) and magnetic pressure (from labeling, toward the guides) acting on cells. The MICS device (Physique1B) is usually a low-cost (<$50/chip), high-throughput (>107cells/h) cell sorter. Target cells are deflected laterally by sets of angled guides which balance the Stokes drag force (from fluid flow) and the magnetic pressure (from labeling). Phages.